More than three years after it envisaged the need for an action plan to keep pace with ongoing scientific and technological advances, the European Medicines Agency says it now has a pretty clear idea of the key areas it needs to focus on over the next five years.
These areas, to be incorporated in the agency’s “Regulatory Science to 2025” strategy, are fostering innovation in clinical trials, promoting...